ARTICLE | Clinical News
BREVAGen regulatory update
September 9, 2013 7:00 AM UTC
Genetic Technologies said the New York State Department of Health issued a clinical laboratory permit to allow the company to perform its BREVAGen genetic test to determine an individual's risk of dev...